Note: Ingredients listed on restricted chemical lists
EC/CAS
100-51-6
Name of the chemical
Benzyl Alcohol
Concentration
N/A
EC/CAS
9004-64-2
Name of the chemical
hydroxypropylcellulose
Concentration
N/A
EC/CAS
102-71-6
Name of the chemical
triethanolamine
Concentration
≤1 64-67
General Information
Revision date
2020-06-10
Product name
PAZOPANIB TOPICAL GEL AND PLACEBO
Product Synonyms
PAZOPANIB TOPICAL GEL 0.1, 0.5, 1 AND 2%W/W AND PLACEBO * GW786034 TOPICAL GEL
supplier name
GlaxoSmithKline Korea
Icons in SDS
Company Information
company name
GlaxoSmithKline Korea
e-mail address of the competent person responsible for the Safety Data Sheet
msds@gsk.com
GHS Information
Signal word
Warning
Hazard Codes
Hazard statements (CLP)
H373
Hazard statements
Code
Statements
H373
May cause damage to organs through prolonged or repeated exposure
Section 2
SECTION 2: Hazards identification
A. Hazard category/Classification
Physical hazards
Not classified.
Health hazards
Specific target organ toxicity following Category 2 repeated exposure
Environmental hazards
Not classified. B. Warning label items including precautionary statement
Signal word
Warning
Hazard statements
H373 May cause damage to organs through prolonged or repeated exposure.
Prevention
P260 Do not breathe mist/vapours.
Response
P314 Get medical advice/attention if you feel unwell.
Disposal
P501 Dispose of contents/container (in accordance with related regulations). C. Other hazards not included This material is non-flammable. in the hazard category criteria Caution - Pharmaceutical agent. See section 11 for additional information on health hazards. (e.g. dust explosion hazard)
Additional information
1 % of the mixture consists of component(s) of unknown acute oral toxicity. 5.16 % of the mixture consists of component(s) of unknown acute dermal toxicity. 2 % of the mixture consists of component(s) of unknown acute hazards to the aquatic environment. 2 % of the mixture consists of component(s) of unknown long-term hazards to the aquatic environment.
